Taisho Pharmaceutical Pabron Gold A (Granules) unlicensed product:, product is labelled to contain dihydrocodeine phosphate that is listed on Schedule I of the CDSA
Recalled Product
Taisho Pharmaceutical Pabron Gold A (Granules)
Hazard / Issue
Product safety
Issued by
Drugs and health products
⚠️ What You Should Do
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Were you affected by this recall?
If you were harmed by a recalled product, you may have legal options. Consider speaking with a consumer protection lawyer in your province.
Looking for safe alternatives?
Browse certified-safe products in this category on Amazon Canada →
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime